Oral administration of esculin at doses of 5, 10, and 25 mg/Kg with TNBS-induced intestinal inflammation in rats alleviated the symptoms of gut damage, reducing MPO activity and counteracting GSH depletion when treated with 25 mg/Kg [84]. The gene discussed is MPO; the disease is inflammatory response.